DIVIS LABORATORIES plunges by 5%; BSE HEALTHCARE Index Up 2.0%

DIVIS LABORATORIES share price has plunged 5% and is presently trading at Rs 1,170.

Meanwhile, the BSE HEALTHCARE Index is at 13,354 (Up 2.0%).

Among the top losers in the BSE HEALTHCARE Index today is DIVIS LABORATORIES (down 5.39%)

SUN PHARMA ADV. RES. (up 9.20%) and SUN PHARMA (up 6.88%) are among the top gainers today.

Over the last one year, DIVIS LABORATORIES has moved up from Rs 551 to Rs 1,170, registering a gain of Rs 619 (up 112.23%).

The BSE HEALTHCARE has moved down from 13,695 to 13,354, loss of 341 points (down 2.49%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were BIOCON LTD (up 114.37%), DIVIS LABORATORIES (up 96.62%) and ABBOTT INDIA (up 64.98%).

What About the Benchmark Indices?

The BSE Sensex is at 35,216 (up 0.79%). The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 6.88%), GAIL (up 4.22%) and BHEL (up 4.20%). Other gainers include COAL INDIA (up 3.33%) and MARUTI SUZUKI (up 2.49%). The most traded stocks in the BSE Sensex are RELIANCE IND. and SUN PHARMA.

In the meantime, NSE Nifty is at 10,702 (up 0.85%). SUN PHARMA (up 6.83%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 30,750 to 35,216, registering a gain of 4,466 points (up 14.48%).

DIVIS LABORATORIES Financial Update...

DIVIS LABORATORIES net profit grew 116.4% YoY to Rs 3 billion for the quarter ended March 2018, compared to a profit of Rs 2 billion a year ago. Net Sales rose 104.8% to Rs 10.9 billion during the period as against Rs 10.4 billion in January-March 2017.

For the year ended March 2017, DIVIS LABORATORIES reported 94.2% increase in net profit to Rs 10.6 billion compared to net profit of Rs 11.3 billion during FY16.

Revenue of the company grew 107.9% to Rs 41 billion during FY17.

The current Price to earnings ratio of DIVIS LABORATORIES, based on rolling 12 month earnings, stands at 33.1x.

This article was originally published in English at www.equitymaster.com

Read the complete Indian stock market update. For the terms of use, go here.